Publiziert in: Marktpuls, Unternehmen
Frei

Roche Investor Update: Reminder: Invitation to Roche Analyst Event on Diagnostics Division at AACC 2016 Dienstag, 19. Juli 2016 - 10:05

Roche - Investor Update

Basel, 19 July 2016
visual.jpg
We are pleased to invite you to an analyst event on Tuesday, 2nd August 2016 to discuss Roche's Diagnostics Division, in conjunction with the American Association for Clinical Chemistry (AACC) Annual Meeting and Clinical Lab Exposition in Philadelphia, Pennsylvania (July 31-August 4, 2016). 

AACC brings together the global leaders in clinical chemistry, molecular diagnostics and lab management, and is the largest dedicated exhibition of equipment, instruments and services for clinical laboratories in the world.

The Analyst Event will start with an update on Roche Diagnostics HY 2016 results followed by a Q&A session on the Division and AACC highlights.
Venue: 
The Warwick Hotel Rittenhouse Square
Meeting room: Grand Ballroom (Mezzanine Level)
220 South 17th Street
Philadelphia, PA 19103 
> map
Date/Time:
Tuesday, 2 August 2016
5:30 pm EDT Registration desk opens
6:00 pm EDT Start of meeting
7:15 pm EDT End of meeting followed by a reception
> Download to my calendar (download to your calendar will be in local time Philadelphia)
Presenter/Panelists:
Roland Diggelmann, CEO Roche Diagnostics
Paul Brown, Head of Roche Molecular Diagnostics
Jean-Claude Gottraux, Global Head of Centralised and Point of Care Solutions
Jack Phillips, Head of Roche Diagnostics North America

To register for the event, please follow the link (Password: Analyst2016)
Dial in to the conference 10-15 minutes prior to the scheduled start, using the following dial-in numbers (listen-only mode, no live-access to speakers):
+41 (0)58 310 50 00 (Europe and ROW) or
+44 (0)203 059 58 62 (UK) or
+1 (1)631 570 5613 (USA)

To expedite the registration process on the day of the conference call, you may pre-register for the event. > click here
Alternatively a live audio webcast can be accessed via http://ir.roche.com.
The presentation slides will be available from the IR website at http://ir.roche.com at the beginning of the event.
A replay of the webcast will be available on demand on the Roche website. > click here
Best regards, 
Dr. Karl Mahler
Head of Investor Relations
 
Dr. Birgit Masjost
Investor Relations Officer
Up
Roche Investor Relations
Dr. Karl Mahler 
Phone: +41 61 68-78503 
e-mail: karl.mahler@roche.com
Dr. Sabine Borngräber 
Phone: +41 61 68-88027
e-mail: sabine.borngraeber@roche.com
Dr. Bruno Eschli 
Phone: +41 61 68-75284 
e-mail: bruno.eschli@roche.com
Dr. Tamer Farhan 
Phone: +41 61 68-82552 
e-mail: tamer.farhan@roche.com
Dr. Birgit Masjost
Phone: +41 61 68-84814 
e-mail: birgit.masjost@roche.com
 
Investor Relations North America
Neera Dahiya Ravindran, MD 
Phone: +1 650 491 5281 
e-mail: ravindran.neera@gene.com
Nina Goworek 
Phone: +1 650 467-8737 
e-mail: goworek.nina@gene.com
19 July 2016      Content owner: Roche Investor Relations    ©2016 F. Hoffmann-La Roche Ltd.